Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lifeloc Technologies ( (LCTC) ) has issued an update.
On August 26, 2025, Lifeloc Technologies amended its license agreement with National Technology & Engineering Solutions of Sandia, LLC. The amendment addresses U.S. competitiveness requirements, change of control, assignment, and milestone obligations, potentially impacting the company’s operational strategies and stakeholder interests.
The most recent analyst rating on (LCTC) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Lifeloc Technologies stock, see the LCTC Stock Forecast page.
Spark’s Take on LCTC Stock
According to Spark, TipRanks’ AI Analyst, LCTC is a Neutral.
Lifeloc Technologies faces significant financial challenges, with declining revenues and negative profitability margins being the most critical factors. The technical analysis shows some positive momentum, but valuation concerns due to negative earnings weigh heavily on the stock’s attractiveness. The absence of earnings call insights and corporate events further limits the potential for a higher score.
To see Spark’s full report on LCTC stock, click here.
More about Lifeloc Technologies
Lifeloc Technologies, Inc. operates in the technology industry, focusing on developing and manufacturing portable breath alcohol testers and related accessories.
Average Trading Volume: 3,363
Technical Sentiment Signal: Sell
Current Market Cap: $8.86M
For a thorough assessment of LCTC stock, go to TipRanks’ Stock Analysis page.